HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chapelier, A. Articles by Lafont, D. Search for Related Content PubMed PubMed Citation Articles by Chapelier, A. Articles by Lafont, D.

The Journal of Thoracic and Cardiovascular Surgery, Vol 106, 299-307, Copyright © 1993 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Comparative outcome of heart-lung and lung transplantation for pulmonary hypertension

A Chapelier, P Vouhe, P Macchiarini, B Lenot, J Cerrina, F Le Roy Ladurie, F Parquin, P Herve, F Brenot and D Lafont
Department of Thoracic and Vascular Surgery, Hopital Marie-Lannelongue, Plessis Robinson, France.

Despite the development of several lung transplantation procedures, the most advantageous for pulmonary hypertension remains controversial. Between 1986 and February 1992, 30 patients with end-stage primary pulmonary hypertension (n = 24), chronic pulmonary embolism (n = 4), and hystiocytosis X (n = 2) underwent heart-lung (n = 21), double lung (n = 8), or single lung (n = 1) transplantation. Indications for double lung transplantation were similar to those for heart-lung transplantation, and the preoperative clinical and hemodynamic parameters were not significantly different between the two groups. There were no intraoperative deaths, but two reoperations were needed for pleural hematoma. Five early deaths were related to graft failure (two heart-lung transplantations), mediastinitis (one heart-lung transplantation), multiorgan failure (one double lung transplantation), and aspergillosis (one double lung transplantation). There was a similar improvement in early (days 0 and 2) and late (6 months postoperatively) right-sided hemodynamic function in patients undergoing heart-lung and double lung transplantation. Three double lung transplant recipients had early and reversible left ventricular- failure. The early postoperative course of the one patient who had single lung transplantation was characterized by severe pulmonary edema, left ventricular failure, and persistent desaturation and later on by moderate pulmonary hypertension and an important ventilation/perfusion mismatch. The pulmonary function results were also similar in the heart-lung and double lung transplantation groups. The overall projected 2- and 4-year survivals were 49% and 41%, respectively, and were not significantly different between the heart- lung and double lung recipients. Results demonstrate that heart-lung and double lung transplantation are equally effective in obtaining early and durable right-sided hemodynamic and respiratory improvement and similar respiratory function. In patients with pulmonary hypertension, double lung transplantation should be preferred to single lung transplantation because of the critical postoperative course and the uncertain long-term results of single lung transplantation.

This article has been cited by other articles:

				M. E. Bowdish, R. Pessotto, R. G. Barbers, F. A. Schenkel, V. A. Starnes, and M. L. Barr Long-term Pulmonary Function After Living-Donor Lobar Lung Transplantation in Adults Ann. Thorac. Surg., February 1, 2005; 79(2): 418 - 425. [Abstract] [Full Text] [PDF]

				Y. Okada, Y. Hoshikawa, Y. Ejima, Y. Matsumura, T. Sado, K. Shimada, H. Aikawa, T. Sugawara, Y. Matsuda, T. Takahashi, et al. {beta}-Blocker prevented repeated pulmonary hypertension episodes after bilateral lung transplantation in a patient with primary pulmonary hypertension J. Thorac. Cardiovasc. Surg., November 1, 2004; 128(5): 793 - 794. [Full Text] [PDF]

				P. Dartevelle, E. Fadel, S. Mussot, A. Chapelier, P. Herve, M. de Perrot, J. Cerrina, F.L. Ladurie, D. Lehouerou, M. Humbert, et al. Chronic thromboembolic pulmonary hypertension Eur. Respir. J., April 1, 2004; 23(4): 637 - 648. [Abstract] [Full Text] [PDF]

				J. Lewczuk, P. Piszko, J. Jagas, A. Porada, S. Wojciak, B. Sobkowicz, and K. Wrabec Prognostic Factors in Medically Treated Patients With Chronic Pulmonary Embolism Chest, March 1, 2001; 119(3): 818 - 823. [Abstract] [Full Text] [PDF]

				S. S. Huerd, T. N. Hodges, F. L. Grover, J. R. Mault, M. B. Mitchell, D. N. Campbell, S. Aziz, P. Chetham, F. Torres, and M. R. Zamora SECONDARY PULMONARY HYPERTENSION DOES NOT ADVERSELY AFFECT OUTCOME AFTER SINGLE LUNG TRANSPLANTATION J. Thorac. Cardiovasc. Surg., March 1, 2000; 119(3): 458 - 465. [Abstract] [Full Text] [PDF]

				T. Ueno, J. A. Smith, G. I. Snell, T. J. Williams, T. C. Kotsimbos, M. Rabinov, and D. S. Esmore Bilateral sequential single lung transplantation for pulmonary hypertension and Eisenmenger’s syndrome Ann. Thorac. Surg., February 1, 2000; 69(2): 381 - 387. [Abstract] [Full Text] [PDF]

				R. J. Barst, L. J. Rubin, W. A. Long, M. D. McGoon, S. Rich, D. B. Badesch, B. M. Groves, V. F. Tapson, R. C. Bourge, B. H. Brundage, et al. A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension N. Engl. J. Med., February 1, 1996; 334(5): 296 - 301. [Abstract] [Full Text] [PDF]